Neonc Technologies (NASDAQ:NTHI) President Amir Heshmatpour Acquires 24,000 Shares

Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) President Amir Heshmatpour bought 24,000 shares of the firm’s stock in a transaction that occurred on Friday, November 21st. The stock was acquired at an average price of $6.07 per share, for a total transaction of $145,680.00. Following the transaction, the president owned 2,986,000 shares in the company, valued at $18,125,020. This trade represents a 0.81% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Neonc Technologies Stock Performance

NTHI stock traded up $1.46 on Monday, reaching $7.32. The company’s stock had a trading volume of 88,158 shares, compared to its average volume of 126,910. Neonc Technologies Holdings, Inc. has a 12-month low of $3.20 and a 12-month high of $25.00. The business has a fifty day simple moving average of $10.04 and a two-hundred day simple moving average of $7.45.

Neonc Technologies (NASDAQ:NTHI) last issued its quarterly earnings results on Friday, November 14th. The company reported ($0.45) EPS for the quarter.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “sell (e)” rating on shares of Neonc Technologies in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Neonc Technologies currently has a consensus rating of “Sell”.

Hedge Funds Weigh In On Neonc Technologies

Hedge funds have recently made changes to their positions in the company. HCR Wealth Advisors purchased a new stake in shares of Neonc Technologies in the second quarter worth about $54,000. Foundations Investment Advisors LLC acquired a new position in shares of Neonc Technologies during the 3rd quarter worth approximately $100,000. SLT Holdings LLC acquired a new stake in Neonc Technologies during the third quarter worth about $100,000. LVW Advisors LLC acquired a new position in shares of Neonc Technologies in the 2nd quarter valued at $108,000. Finally, Royal Bank of Canada acquired a new position in shares of Neonc Technologies in the 1st quarter worth approximately $247,000.

About Neonc Technologies

Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing.